NCT05908669View on ClinicalTrials.gov

Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme

Enrolling by invitationOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

August 25, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

December 31, 2026

Conditions
Glioblastoma Multiforme
Interventions
DIAGNOSTIC_TEST

Deuterium metabolic imaging

MRI after oral administration of 75g of \[6,6'-2H2\]glucose.

Trial Locations (1)

8200

Aarhus University, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER